Bausch Health Companies Inc. reported $10.5B of revenue over the trailing twelve months, +8.2% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $10.5B (to Q1 2026). Net Income: −$1.23B, trailing twelve months to Q1 2026. Free Cash Flow: $1.03B, trailing twelve months to Q1 2026. Op Margin: 5.0%, trailing twelve months to Q1 2026.

BHCBausch Health Companies Inc.

HealthcareUSD

$6.51

$4.4452 weeks$8.34

BHC as reported

Bausch Health Companies Inc. reported $10.5B of revenue over the trailing twelve months, +8.2% on the year before. 10 reported series are charted on this page, each one as filed.

$10.5B

Revenue, trailing twelve months · to Q1 2026 · +8.2% against the twelve months before

Net Income: −$1.23B
Net Income · +1412% year on year · trailing twelve months to Q1 2026
Free Cash Flow: $1.03B
Free Cash Flow · −16% year on year · trailing twelve months to Q1 2026
Op Margin: 5.0%
Op Margin · trailing twelve months to Q1 2026

Every series Ryufin has for BHC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$10.5B	+8.2%	Q1 2026
Net Income	−$1.23B	+1412%	Q1 2026
EPS	−$3.24	+2845%	Q1 2026
Gross Margin	71%	n/a	Q2 2018 · 31 quarters behind
Op Margin	5.0%	n/a	Q1 2026
Net Margin	−12%	n/a	Q1 2026
ROE	−6.3%	n/a	Q1 2026
ROA	−0.79%	n/a	Q1 2026
ROIC	6.1%	n/a	Q1 2026
Free Cash Flow	$1.03B	−16%	Q1 2026